Almost a 25% drop in shareprice since the Fast track...

Almost a 25% drop in shareprice since the Fast track announcement on the 19th March, surely I am living in Bazaro world.
With 3 active trials on the go the B-cel trial in UK just starting to enrol, not one bit of bad news from any of the trials and we sit at .032c, MADNESS!!!

On the positive side of things Recruitment of key personnel must mean that there is confidence in the future, we are not downsizing, now I know that some feel aggrieved as this does mean increased cost, however every business owner knows that you must spend money to make money.

No change to major holdings according to the March Newsletter and progress continues.

I know that I am looking forward to our Cholangiocarcinoma patient reaching the 3 year milestone as will many others, both for their sake and for the "C" word to start being bandied around on every news network available.
This should be within the next 10 months if memory serves me correctly, I am sure that there will be somone here to let me know I am wrong if that is the not the case.

I really am missing the valuable input of many of our more sensible contributors and as in any void it tends to be filled with S**t, of course I would expect their return when there is something of value to comment on, let's all hope that there is something of value in the next few months.

Thankyou to Leslie and her team for working so hard to bring a drug/s to market, those with other bio's know how difficult this can be, and while some may feel thing are dragging along, those that count, i.e. Yuman Fong know really how swiftly things are progressing.


DYOR opinion only